Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Scientific Reports
|
May 23, 2019
Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031
Awa Sarr, Jennifer Bré, In Hwa Um, et al.
Cancer Research
|
August 3, 2005
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer
Kenneth Macleod, Peter Mullen, Jane Sewell, et al.
Npj Imaging
|
September 16, 2025
Kidney tumoroid characterisation by spatial mass spectrometry with same-section multiplex immunofluorescence uncovers tumour microenvironment lipid signatures associated with aggressive tumour phenotypes
Hazem Abdullah, Greice M Zickuhr, In Hwa Um, et al.
Cancer Treatment Reviews
|
October 16, 2012
New strategies for targeting the hypoxic tumour microenvironment in breast cancer
Carol Ward, Simon P Langdon, Peter Mullen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 26, 2016
Embedding a Panoramic Representation of Infrared Light in the Adult Rat Somatosensory Cortex through a Sensory Neuroprosthesis
Konstantin Hartmann, Eric E Thomson, Ivan Zea, et al.
Carcinogenesis
|
December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells
Fiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.
Cancer Research
|
August 5, 2008
Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo
Kevin Morgan, Alan J Stewart, Nicola Miller, et al.
Plos One
|
April 20, 2012
Diversity of matriptase expression level and function in breast cancer
Arkadiusz Welman, Duncan Sproul, Peter Mullen, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2012
Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines
Jean-Yves Winum, Fabrizio Carta, Carol Ward, et al.
BMC Medicine
|
June 27, 2017
Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer
Alexander L R Lubbock, Grant D Stewart, Fiach C O'Mahony, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Scientific Reports
|
May 23, 2019
Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031
Awa Sarr, Jennifer Bré, In Hwa Um, et al.
Cancer Research
|
August 3, 2005
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer
Kenneth Macleod, Peter Mullen, Jane Sewell, et al.
Npj Imaging
|
September 16, 2025
Kidney tumoroid characterisation by spatial mass spectrometry with same-section multiplex immunofluorescence uncovers tumour microenvironment lipid signatures associated with aggressive tumour phenotypes
Hazem Abdullah, Greice M Zickuhr, In Hwa Um, et al.
Cancer Treatment Reviews
|
October 16, 2012
New strategies for targeting the hypoxic tumour microenvironment in breast cancer
Carol Ward, Simon P Langdon, Peter Mullen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 26, 2016
Embedding a Panoramic Representation of Infrared Light in the Adult Rat Somatosensory Cortex through a Sensory Neuroprosthesis
Konstantin Hartmann, Eric E Thomson, Ivan Zea, et al.
Carcinogenesis
|
December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells
Fiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.
Cancer Research
|
August 5, 2008
Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo
Kevin Morgan, Alan J Stewart, Nicola Miller, et al.
Plos One
|
April 20, 2012
Diversity of matriptase expression level and function in breast cancer
Arkadiusz Welman, Duncan Sproul, Peter Mullen, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2012
Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines
Jean-Yves Winum, Fabrizio Carta, Carol Ward, et al.
BMC Medicine
|
June 27, 2017
Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer
Alexander L R Lubbock, Grant D Stewart, Fiach C O'Mahony, et al.
Page
of 5